107 related articles for article (PubMed ID: 15043208)
1. HIV capsid assembly.
Morikawa Y
Curr HIV Res; 2003 Jan; 1(1):1-14. PubMed ID: 15043208
[TBL] [Abstract][Full Text] [Related]
2. A novel fluorescence resonance energy transfer assay demonstrates that the human immunodeficiency virus type 1 Pr55Gag I domain mediates Gag-Gag interactions.
Derdowski A; Ding L; Spearman P
J Virol; 2004 Feb; 78(3):1230-42. PubMed ID: 14722278
[TBL] [Abstract][Full Text] [Related]
3. The functionally exchangeable L domains in RSV and HIV-1 Gag direct particle release through pathways linked by Tsg101.
Medina G; Zhang Y; Tang Y; Gottwein E; Vana ML; Bouamr F; Leis J; Carter CA
Traffic; 2005 Oct; 6(10):880-94. PubMed ID: 16138902
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress.
Martin-Serrano J; Zang T; Bieniasz PD
Nat Med; 2001 Dec; 7(12):1313-9. PubMed ID: 11726971
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 Vpr Abrogates the Effect of TSG101 Overexpression to Support Virus Release.
Chutiwitoonchai N; Siarot L; Takeda E; Shioda T; Ueda M; Aida Y
PLoS One; 2016; 11(9):e0163100. PubMed ID: 27648839
[TBL] [Abstract][Full Text] [Related]
6. Defects in human immunodeficiency virus budding and endosomal sorting induced by TSG101 overexpression.
Goila-Gaur R; Demirov DG; Orenstein JM; Ono A; Freed EO
J Virol; 2003 Jun; 77(11):6507-19. PubMed ID: 12743307
[TBL] [Abstract][Full Text] [Related]
7. Critical Role of the Human T-Cell Leukemia Virus Type 1 Capsid N-Terminal Domain for Gag-Gag Interactions and Virus Particle Assembly.
Martin JL; Mendonça LM; Marusinec R; Zuczek J; Angert I; Blower RJ; Mueller JD; Perilla JR; Zhang W; Mansky LM
J Virol; 2018 Jul; 92(14):. PubMed ID: 29695435
[TBL] [Abstract][Full Text] [Related]
8. The HIV-1 capsid protein C-terminal domain in complex with a virus assembly inhibitor.
Ternois F; Sticht J; Duquerroy S; Kräusslich HG; Rey FA
Nat Struct Mol Biol; 2005 Aug; 12(8):678-82. PubMed ID: 16041386
[TBL] [Abstract][Full Text] [Related]
9. Equine infectious anemia virus utilizes host vesicular protein sorting machinery during particle release.
Tanzi GO; Piefer AJ; Bates P
J Virol; 2003 Aug; 77(15):8440-7. PubMed ID: 12857913
[TBL] [Abstract][Full Text] [Related]
10. Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body.
Ono A; Freed EO
J Virol; 2004 Feb; 78(3):1552-63. PubMed ID: 14722309
[TBL] [Abstract][Full Text] [Related]
11. HIV Gag mimics the Tsg101-recruiting activity of the human Hrs protein.
Pornillos O; Higginson DS; Stray KM; Fisher RD; Garrus JE; Payne M; He GP; Wang HE; Morham SG; Sundquist WI
J Cell Biol; 2003 Aug; 162(3):425-34. PubMed ID: 12900394
[TBL] [Abstract][Full Text] [Related]
12. Tsg101: HIV-1's ticket to ride.
Carter CA
Trends Microbiol; 2002 May; 10(5):203-5. PubMed ID: 11973141
[TBL] [Abstract][Full Text] [Related]
13. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag).
VerPlank L; Bouamr F; LaGrassa TJ; Agresta B; Kikonyogo A; Leis J; Carter CA
Proc Natl Acad Sci U S A; 2001 Jul; 98(14):7724-9. PubMed ID: 11427703
[TBL] [Abstract][Full Text] [Related]
14. The C-terminal half of TSG101 blocks Rous sarcoma virus budding and sequesters Gag into unique nonendosomal structures.
Johnson MC; Spidel JL; Ako-Adjei D; Wills JW; Vogt VM
J Virol; 2005 Mar; 79(6):3775-86. PubMed ID: 15731271
[TBL] [Abstract][Full Text] [Related]
15. Tsg101 control of human immunodeficiency virus type 1 Gag trafficking and release.
Goff A; Ehrlich LS; Cohen SN; Carter CA
J Virol; 2003 Sep; 77(17):9173-82. PubMed ID: 12915533
[TBL] [Abstract][Full Text] [Related]
16. AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding.
Strack B; Calistri A; Craig S; Popova E; Göttlinger HG
Cell; 2003 Sep; 114(6):689-99. PubMed ID: 14505569
[TBL] [Abstract][Full Text] [Related]
17. The C-terminal portion of the Hrs protein interacts with Tsg101 and interferes with human immunodeficiency virus type 1 Gag particle production.
Bouamr F; Houck-Loomis BR; De Los Santos M; Casaday RJ; Johnson MC; Goff SP
J Virol; 2007 Mar; 81(6):2909-22. PubMed ID: 17182674
[TBL] [Abstract][Full Text] [Related]
18. AP-3 directs the intracellular trafficking of HIV-1 Gag and plays a key role in particle assembly.
Dong X; Li H; Derdowski A; Ding L; Burnett A; Chen X; Peters TR; Dermody TS; Woodruff E; Wang JJ; Spearman P
Cell; 2005 Mar; 120(5):663-74. PubMed ID: 15766529
[TBL] [Abstract][Full Text] [Related]
19. The Mason-Pfizer monkey virus internal scaffold domain enables in vitro assembly of human immunodeficiency virus type 1 Gag.
Sakalian M; Dittmer SS; Gandy AD; Rapp ND; Zábranský A; Hunter E
J Virol; 2002 Nov; 76(21):10811-20. PubMed ID: 12368324
[TBL] [Abstract][Full Text] [Related]
20. Mutagenesis of N-terminal residues of feline foamy virus Gag reveals entirely distinct functions during capsid formation, particle assembly, Gag processing and budding.
Liu Y; Betts MJ; Lei J; Wei G; Bao Q; Kehl T; Russell RB; Löchelt M
Retrovirology; 2016 Aug; 13(1):57. PubMed ID: 27549192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
